fusidic acid

Trade name: Fucidin

Small moleculeexperimental

Fusidic acid, sold under the brand name Fucidin among others, is an antibiotic that is often used topically in creams or ointments and eyedrops but may also be given systemically as tablets or injections. As of October 2008, the global problem of advancing antimicrobial resistance has led to a renewed interest in its use. — Wikipedia

Clinical trial activity

16 trials · 13 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
9
Phase 3
6
Phase 4
3

Earliest trial started May 1, 2004 (NCT00986856)

Timeline

2000s

  1. Jan 1, 2009

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2009

    Earliest Phase 3 Sponsor(trial)

2010s

  1. Jan 1, 2019

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\CCC=C(C)C)C(=O)O
Mol. weight
516.72 g/mol
Lipinski Ro5
2 violation(s)
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • cem-102
  • cem-102
  • flucidin
  • fucidin caviject
  • fucidine
  • fucidine
  • fucithalmic
  • fucithalmic
  • fucithalmic
  • fusidate sodium
  • fusidate sodium
  • fusidic acid
  • fusidic acid
  • fusidic acid
  • fusidic acid
  • fusidic acid
  • fusidic acid
  • fusidic acid sodium
  • fusidic acid sodium salt
  • fusidinic acid
  • silver fusidate
  • silver fusidate
  • silver fusidate
  • silver fusidate
  • silver fusidate
  • silver fusidate
  • sodium fusidate
  • sodium fusidate
  • sodium fusidate
  • sodium fusidate
  • sq-16360
  • sq-16360
  • sq-16603
  • sq-16603

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06911424Phase 3Mar 21, 2025Baxis Pharmaceuticals, Inc.
NCT05641298Phase 2Dec 31, 2022Aceragen
NCT05398679Phase 4Jun 1, 2022University of Barcelona
NCT05105035Phase 2May 31, 2022Arrevus Inc.
NCT05353374N/AJan 1, 2021University of Indonesia
NCT03816618Early Phase 1 (Phase 1)Feb 1, 2019Cyberjaya University College of Medical Sciences
NCT03395132Phase 3Jul 31, 2018Leo Pharma
NCT03052348N/ANov 1, 2017Red Cross War Memorial Childrens Hospital
NCT03105505Phase 4Apr 28, 2017Barzilai Medical Center
NCT02569541Phase 2/Phase 3 (Phase 3)Dec 1, 2015Cempra Inc
NCT02570490Phase 3Nov 1, 2015Cempra Inc
NCT01756924Phase 2Dec 1, 2012Cempra Inc
NCT01113125Phase 3Mar 1, 2010Aarhus University
NCT00948142Phase 2Aug 1, 2009Cempra Inc
NCT00718315Phase 3Apr 1, 2009Roche
NCT00986856Phase 4May 1, 2004Leo Pharma, Lund University
Showing 16 of 16 trials
Page 1 / 1

Organizations

Research & Development (13)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Cempra IncFor profit4422009
Leo PharmaFor profit2222004
Aarhus UniversityAcademic/Hospital1112010
AceragenFor profit1112022
Arrevus Inc.For profit1112022
Barzilai Medical CenterAcademic/Hospital1112017
Baxis Pharmaceuticals, Inc.For profit1112025
Cyberjaya University College of Medical SciencesAcademic/Hospital1112019
Lund UniversityAcademic/Hospital1012004
Red Cross War Memorial Childrens HospitalAcademic/Hospital1112017
RocheFor profit1112009
University of BarcelonaAcademic/Hospital1112022
University of IndonesiaAcademic/Hospital1112021
13 organizations
Page 1 / 1